Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients

Acta Anaesthesiologica Scandinavica

Volumn 52, Issue 2, 2008, Pages 229-235

  Meyer, P ^a   Pernet, P ^a   Hejblum, G ^a,b,c   Baudel, J L ^a   Maury, E ^a,b,c   Offenstadt, G ^a,b,c   Guidet, B ^a,b,c  

^a HÔPITAL SAINT ANTOINE   (France)

^b INSERM   (France)

^c SORBONNE UNIVERSITÉ   (France)

Author keywords

Capillary leak; Haemodilution; Hypovolaemia; Sepsis; Starches

Indexed keywords

ALBUMIN; HETASTARCH; NORADRENALIN; PLASMA SUBSTITUTE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CAPILLARY LEAK SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE MARKER; FLUID THERAPY; HEMATOCRIT; HEMODILUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOVOLEMIA; INTRAVASCULAR SPACE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PLASMA VOLUME; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SEPSIS; SEPTICEMIA; TREATMENT OUTCOME;

AGED; BLOOD PRESSURE; BLOOD PROTEINS; BLOOD VISCOSITY; CRITICAL ILLNESS; HEART RATE; HEMATOCRIT; HEMODILUTION; HETASTARCH; HUMANS; HYPOVOLEMIA; MIDDLE AGED; PLASMA SUBSTITUTES; PROSPECTIVE STUDIES; SEPSIS; SERUM ALBUMIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 38149082090     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2007.01521.x     Document Type: Article

References (35)

1. Annane D, Aegerter P for the CUB-R é a Network et al. Current epidemiology of septic shock. Am J Respir Crit Care Med 2003 168 : 165 72.
2. Guidet B, Aegerter P CUB-Rea Study Group et al. Incidence and impact of organ dysfunction associated with severe sepsis. Chest 2005 127 : 942 51.
3. Dellinger RP, Carlet JM, Masur H et al. Surviving sepsis campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004 32 : 858 73.
4. Finfer S, Bellomo R SAFE Study investigators et al. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004 350 : 2247 56.
5. Choi PT, Yip G, Quinonez LG et al. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999 27 : 200 10.
6. Svensen C, Hahn RG. Volume kinetics of Ringer solution, Dextran 70, and hypertonic saline in male volunteers. Anesthesiology 1997 87 : 204 12.
7. Jungheinrich C, Neff TA. Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 2005 7 : 681 99.
8. American Thoracic Society. Evidence-based colloid use in the critically ill: American thoracic society consensus statement. Am J Respir Crit Care Med 2004 170 : 1247 59.
9. Persson J. Physiological and clinical aspects of change in microvascular permeability. Acta Anaesthesiol Scand 2006 50 : 628.
10. Marx G, Cobas Meyer M, Schuerholz T et al. Hydroxyethyl starch and modified gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage. Intensive Care Med 2002 28 : 629 35.
11. Marx G, Pedder S, Smith L et al. Resuscitation from septic shock with capillary leakage: hydroxyethyl starch (130 kD), but not Ringer's solution maintains plasma volume and systemic oxygenation. Shock 2004 21 : 336 41.
12. Persson J, Per-Olof G. Plasma volume expansion and transcapillary fluid exchange in skeletal muscle of albumin, dextran, gelatin, hydroxyethyl starch, and saline after trauma in the cat. Crit Care Med 2006 34 : 2456 62.
13. Li Y, Zhu S, Hahn RG. The kinetic's of Ringer solution in young and elderly patients during induction of general anesthesia with propofol and epidural anesthesia with ropivacaine. Acta Anaesthesiol Scand 2007 51 : 880 7.
14. Hedin A, Hahn R. Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci 2005 108 : 217 24.
15. Margarson MP, Soni NC. Plasma volume measurement in septic patients using an albumin dilution technique: comparison with the standard radio-labelled albumin method. Intensive Care Med 2005 31 : 289 95.
16. Waitzinger J, Bepperling F, Pabst G et al. Pharmacokinetics and tolerability of a new hydroxyethyl starch (HES) specification [HES (130/0.4)] after single-dose infusion of 6% or 10% solutions in healthy volunteers. Clin Drug Invest 1998 16 : 151 60.
17. Jungheinrich C, Scharppf R, Wargenau M et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethylstarch 130/0.4 (6%, 500 ml) in mild-to-severe renal impairment. Anesth Analg 2002 95 : 544 51.
18. Bone RC, Balk RA, Cerra FB et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM consensus conference committee. American College of Chest Physicians/Society of critical care medicine. Chest 1992 101 : 1644 55.
19. Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 1993 270 : 2957 63.
20. Hollander M, Wolfe DA. The two-way layout. In : Hollander M, Wolfe DA, eds. Nonparametric statistical methods, 2nd edn. New-York : Wiley series in probability and statistics, 1999 : 270 363.
21. Altman DG. Some common problems in medical research; serial measurements. In : Altman DG, ed. Practical statistics for medical research, 2nd edn. London : Chapman & Hall, CRC, 1999 : 426 33.
22. Sommermeyer K, Cech F, Schmidt M et al. Klinisch verwendete Hydroxyethylstarke: Physikalisch-chemische Charakterisierung. Krankenhauspharmazie 1987 8 : 271 8.
23. Margarson MP, Soni NC. Changes in serum albumin concentration and volume expanding effects following a bolus of albumin 20% in septic patients. Br J Anaesthesiol 2004 92 : 821 6.
24. Molnar Z, Mikor A, Leiner T et al. Fluid resuscitation with colloids of different molecular weight in septic shock. Intensive Care Med 2004 30 : 1356 60.
25. Matejovic M, Krouzecky A, Rokyta Jr. R et al. Fluid challenge in patients at risk for fluid loading-induced pulmonary edema. Acta Anaesthesiol Scand 2004 48 : 69 73.
26. Svensen C, Clifton B, Brauer KI et al. Sepsis produced by pseudomonas bacteremia does not alter plasma volume expansion after 0.9% saline infusion in sheep. Anesth Analg 2005 101 : 835 42.
27. Zikria BA, King TC, Stanford J et al. A biophysical approach to capillary permeability. Surgery 1989 105 : 625 31.
28. Lv R, Zhou W, Zhang LD et al. Effects of hydroxy-ethyl starch on hepatic production of cytokines and activation of transcriptores factors in lipopolysaccaride-administered rats. Acta Anaesthesiol Scand 2005 49 : 639 42.
29. Feng X, Ren B, Xie W et al. influence of hydroxyethyl starch 130/0.4 in pulmonary neutrophil recruitment and acute lung injury during polymicrobial sepsis in rats. Acta Anaesthesiol Scand 2006 50 : 1081 8.
30. Boldt J, Ducke M, Kumle B et al. Influence of different replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med 2004 30 : 416 22.
31. Lang K, Suttner S, Boldt J et al. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Can J Anesthesiol 2003 50 : 1009 16.
32. Boldt J, Heesen M, Padberg W et al. The influence of volume therapy and pentoxifylline infusion on circulating adhesion molecules in trauma patients. Anaesthesia 1996 51 : 529 35.
33. Chen G, Yan M, Lu QH et al. Effects of two different hydroxyethyl starch solutions (HES 200/0.5 vs HES 130/0.4) on the expression of platelet membrane glycoprotein. Acta Anaesthesiol Scand 2006 50 : 1089 94.
34. Lang K, Boldt J, Suttner S et al. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery. Anesthesiol Analg 2001 93 : 405 9.
35. Standl T, Burmeister MA, Shroeder F et al. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehaemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic haemodilution. Anesth Analg 2003 96 : 936 43.